Evidence map›Paper›PMID 14747529›Full record

ArticleJournal of virology2004

Active Akt and functional p53 modulate apoptosis in Abelson virus-transformed pre-B cells.

Li Gong, Indira Unnikrishnan, Anuradha Raghavan, Kalindi Parmar, Naomi Rosenberg

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Li GongDepartment of Molecular Biology and Microbiology, School of Medicine, Tufts University, Boston, Massachusetts 02111, USA.
Indira Unnikrishnan
Anuradha Raghavan
Kalindi Parmar
Naomi Rosenberg
Tufts University · US

Funding

RNA TUMOR VIRUS/HEMATOPOIETIC CELLS INTERACTIONSR01CA033771 · NCI · TUFTS UNIVERSITY BOSTON · PI ROSENBERG, NAOMI · 1985 to 2007
$2.6M
RNA TUMOR VIRUS-HEMATOPOIETIC CELL INTERACTIONR37CA033771 · NCI · TUFTS UNIVERSITY BOSTON · PI ROSENBERG, NAOMI · 1993 to 1997
–
NCI NIH HHS CA 33771NCI NIH HHS R01 CA033771
6 · The paper itself

Abstract

Suppression of apoptosis is an important feature of the Abelson murine leukemia virus (Ab-MLV) transformation process. During multistep transformation, Ab-MLV-infected pre-B cells undergo p53-dependent apoptosis during the crisis phase of transformation. Even once cells are fully transformed, an active v-Abl protein tyrosine kinase is required to suppress apoptosis because cells transformed by temperature-sensitive (ts) kinase mutants undergo rapid apoptosis after a shift to the nonpermissive temperature. However, inactivation of the v-Abl protein by a temperature shift interrupts signals transmitted via multiple pathways, making it difficult to identify those that are critically important for the suppression of apoptosis. To begin to dissect these pathways, we tested the ability of an SH2 domain Ab-MLV mutant, P120/R273K, to rescue aspects of the ts phenotype of pre-B cells transformed by the conditional kinase domain mutant. The P120/R273K mutant suppressed apoptosis at the nonpermissive temperature, a phenotype correlated with its ability to activate Akt. Apoptosis also was suppressed at the nonpermissive temperature by constitutively active Akt and in p53-null pre-B cells transformed with the ts kinase domain mutant. These data indicate that an intact Src homology 2 (SH2) domain is not critical for apoptosis suppression and suggest that signals transmitted through Akt and p53 play an important role in the response.

Indexed as

ApoptosisCell Transformation, ViralProtein Serine-Threonine KinasesAbelson murine leukemia virusAnimalsB-LymphocytesBone Marrow CellsCell Line, TransformedHumansMiceOncogene Proteins v-ablProto-Oncogene ProteinsProto-Oncogene Proteins c-aktsrc Homology DomainsTumor Suppressor Protein p53AKT1 protein, humanOncogene Proteins v-ablProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktTumor Suppressor Protein p53

Identifiers

PMID14747529
PMCPMC369499
OpenAlexW2059191471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.